FTO and breast cancer: Through virtual screening, structural optimization and bioassay, Xie et al.developed a novel small-molecule FTO inhibitor, 18,097, which selectively bound to FTO active site and significantly inhibited breast cancer cell proliferation and metastasis both in vitro and in vivo (Fig. 6b) [422].